Fresno Community Hospital
Welcome,         Profile    Billing    Logout  
 1 Trial 
13 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rogers, Christopher
CHANGE AFIB, NCT05130268: Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation

Completed
4
339
US
Dronedarone, Multaq
American Heart Association, Duke Clinical Research Institute, Sanofi
Atrial Fibrillation
01/24
06/24
Royal, Mike
NCT04905836: Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress

Recruiting
2
60
US
COVI-MSC, Placebo
Sorrento Therapeutics, Inc.
Covid19
12/22
03/23
NCT04885972: Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis

Active, not recruiting
2
124
US
Resiniferatoxin, RTX, Zilretta, triamcinolone acetonide, Placebo
Sorrento Therapeutics, Inc.
Osteoarthritis, Knee, Knee Osteoarthritis, Knee Pain Chronic
09/23
11/23
NCT05067257: Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer

Suspended
2
120
US
Resiniferatoxin, RTX, Placebo
Sorrento Therapeutics, Inc.
Pain, Intractable, Pain Cancer, Pain
06/27
12/27
NCT04992247: Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise

Withdrawn
2
60
NA
COVI-MSC, Placebo
Sorrento Therapeutics, Inc.
Covid19
07/24
09/24
Maverick, NCT05361915: Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer

Suspended
2
100
US
Abivertinib, STI-5656, Abiraterone
Sorrento Therapeutics, Inc.
Prostate Cancer, Prostate Cancer Metastatic
01/28
01/28
NCT04559412: Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid Arthritis

Active, not recruiting
1b
11
US
Sofusa DoseConnect, sofusa, Enbrel
Sorrento Therapeutics, Inc.
Rheumatoid Arthritis
01/24
12/24
NCT05007418: Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma

Recruiting
1b
54
US
STI-1492
Sorrento Therapeutics, Inc.
Multiple Myeloma
12/25
02/26
OV2-RRST-101, NCT05361954: Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors

Not yet recruiting
1b
36
NA
STI-1386, Seprehvec
Sorrento Therapeutics, Inc.
Cancer, Cancer of Pancreas, Sarcoma, Hepatic Metastasis, Solid Tumor
10/26
02/27
NCT04900519: Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors

Recruiting
1
100
US
STI-6643
Sorrento Therapeutics, Inc.
Solid Tumor, Relapsed Solid Neoplasm, Refractory Tumor
12/24
03/25
NCT05472649: Long-Term Follow-Up of Patients Who Received Gene-Modified Cell Therapy

Enrolling by invitation
N/A
1
US
Gene-Modified Cell Therapy
Sorrento Therapeutics, Inc.
Long-term Follow-up
12/36
05/37
Almasri, Eyad
ARTISAN, NCT05203510: A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension

Active, not recruiting
4
52
US
Parenteral Treprostinil, Remodulin, Oral Treprostinil, Orenitram
United Therapeutics, Lung Biotechnology PBC
Pulmonary Arterial Hypertension
04/26
04/28
NCT06521502: The APS Phenotyping Study

Recruiting
N/A
4000
US
Blood collection, Urine Collection, Nasal, oral, and rectal swabs, Stool collection, Heat Moisture Exchange Filter collection, Tracheal Aspirate sample collection, Non-bronchoscopic bronchoalveolar lavage (NBBAL), Surveys, Short physical performance battery, Hand grip strength, CNS Vital Signs, Muscle Ultrasound, Muscle Strength, Spirometry, Lung Diffusion Testing (DLCO), Chest CT Scan
Vanderbilt University Medical Center
ARDS, Sepsis, Pneumonia
04/28
04/28
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rogers, Christopher
CHANGE AFIB, NCT05130268: Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation

Completed
4
339
US
Dronedarone, Multaq
American Heart Association, Duke Clinical Research Institute, Sanofi
Atrial Fibrillation
01/24
06/24
Royal, Mike
NCT04905836: Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress

Recruiting
2
60
US
COVI-MSC, Placebo
Sorrento Therapeutics, Inc.
Covid19
12/22
03/23
NCT04885972: Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis

Active, not recruiting
2
124
US
Resiniferatoxin, RTX, Zilretta, triamcinolone acetonide, Placebo
Sorrento Therapeutics, Inc.
Osteoarthritis, Knee, Knee Osteoarthritis, Knee Pain Chronic
09/23
11/23
NCT05067257: Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer

Suspended
2
120
US
Resiniferatoxin, RTX, Placebo
Sorrento Therapeutics, Inc.
Pain, Intractable, Pain Cancer, Pain
06/27
12/27
NCT04992247: Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise

Withdrawn
2
60
NA
COVI-MSC, Placebo
Sorrento Therapeutics, Inc.
Covid19
07/24
09/24
Maverick, NCT05361915: Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer

Suspended
2
100
US
Abivertinib, STI-5656, Abiraterone
Sorrento Therapeutics, Inc.
Prostate Cancer, Prostate Cancer Metastatic
01/28
01/28
NCT04559412: Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid Arthritis

Active, not recruiting
1b
11
US
Sofusa DoseConnect, sofusa, Enbrel
Sorrento Therapeutics, Inc.
Rheumatoid Arthritis
01/24
12/24
NCT05007418: Study to Assess Allogeneic Anti-CD38 A2 Dimeric Antigen Receptor T Cells in Relapsed or Refractory Multiple Myeloma

Recruiting
1b
54
US
STI-1492
Sorrento Therapeutics, Inc.
Multiple Myeloma
12/25
02/26
OV2-RRST-101, NCT05361954: Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors

Not yet recruiting
1b
36
NA
STI-1386, Seprehvec
Sorrento Therapeutics, Inc.
Cancer, Cancer of Pancreas, Sarcoma, Hepatic Metastasis, Solid Tumor
10/26
02/27
NCT04900519: Study of the Safety and Efficacy of STI-6643 in Subjects With Advanced Solid Tumors

Recruiting
1
100
US
STI-6643
Sorrento Therapeutics, Inc.
Solid Tumor, Relapsed Solid Neoplasm, Refractory Tumor
12/24
03/25
NCT05472649: Long-Term Follow-Up of Patients Who Received Gene-Modified Cell Therapy

Enrolling by invitation
N/A
1
US
Gene-Modified Cell Therapy
Sorrento Therapeutics, Inc.
Long-term Follow-up
12/36
05/37
Almasri, Eyad
ARTISAN, NCT05203510: A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension

Active, not recruiting
4
52
US
Parenteral Treprostinil, Remodulin, Oral Treprostinil, Orenitram
United Therapeutics, Lung Biotechnology PBC
Pulmonary Arterial Hypertension
04/26
04/28
NCT06521502: The APS Phenotyping Study

Recruiting
N/A
4000
US
Blood collection, Urine Collection, Nasal, oral, and rectal swabs, Stool collection, Heat Moisture Exchange Filter collection, Tracheal Aspirate sample collection, Non-bronchoscopic bronchoalveolar lavage (NBBAL), Surveys, Short physical performance battery, Hand grip strength, CNS Vital Signs, Muscle Ultrasound, Muscle Strength, Spirometry, Lung Diffusion Testing (DLCO), Chest CT Scan
Vanderbilt University Medical Center
ARDS, Sepsis, Pneumonia
04/28
04/28

Download Options